Abstract
Supplementary Figure S2. Study design of JCOG1404/WJOG8214L. Abbreviations: NSCLC, non-small cell lung cancer; EGFR; epidermal growth factor receptor; Exon 19 DEL, EGFR exon 19 deletion; Exon 21 L858R, EGFR exon 21 L858 point mutation; ECOG, Eastern Clinical Oncology Group; PS, performance status; CNS, central nervous system; EGFR-TKI, epidermal growth factor receptor tyrosine kinase inhibitor; PD, progressive disease.